Menu
Back to Journals » Infection and Drug Resistance » Respiratory Syncytial Virus (RSV): progress, challenges and outcomes
Infection and Drug Resistance
ISSN: 1178-6973
- View all (3546)
- Volume 17, 2024 (152)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- Antimicrobial Stewardship and Infection Control: A Global Perspective (2)
- Current aspects of fungal infections (1)
- Advances in Osteomyelitis: Pathogenesis, Diagnosis, and Treatment (1)
- Respiratory Syncytial Virus (RSV): progress, challenges and outcomes (6)
Respiratory Syncytial Virus (RSV): progress, challenges and outcomes
Respiratory Syncytial Virus (RSV) can lead to symptoms akin to the common cold or winter flu, runny nose, cough, fever and so on. During the COVID-19 pandemic, a dip in RSV infections was noted in the United States, meaning the pandemic could have influenced the transmission of RSV during this period. This Thematic Series considers how infection rates prior to the pandemic differ from to those from 2020 onwards. The Series focuses on the factors leading to these changes, the mortality rates for co-morbid COVID-19 and RSV, and the body’s immunity response.
Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies
Dvorkin J, De Luca J, Alvarez-Paggi D, Caballero MT
Infection and Drug Resistance 2023, 16:595-605
Published Date: 27 January 2023
The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review
Chuang YC, Lin KP, Wang LA, Yeh TK, Liu PY
Infection and Drug Resistance 2023, 16:661-675
Published Date: 30 January 2023
New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
Diethelm-Varela B, Soto JA, Riedel CA, Bueno SM, Kalergis AM
Infection and Drug Resistance 2023, 16:2061-2074
Published Date: 8 April 2023
Performance Evaluation of TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR Multiplex Assay for the Detection of Respiratory Viruses
Neopane P, Nypaver J, Shrestha R, Beqaj S
Infection and Drug Resistance 2022, 15:5411-5423
Published Date: 12 September 2022
Age-Dependent Clinical Characteristics of Acute Lower Respiratory Infections in Young Hospitalized Children with Respiratory Syncytial Virus Infection
Li L, Wang H, Liu A, Chen J, Yang Y, Wang W
Infection and Drug Resistance 2022, 15:5971-5979
Published Date: 18 October 2022
Epidemiological Trend of RSV Infection Before and During COVID-19 Pandemic: A Three-Year Consecutive Study in China
Qiu W, Zheng C, Huang S, Zhang Y, Chen Z
Infection and Drug Resistance 2022, 15:6829-6837
Published Date: 28 November 2022